

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.51834623 |
| 2 | muscle filament sliding (GO:0030049) | 6.51834623 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 5.96240777 |
| 4 | sarcomere organization (GO:0045214) | 5.80412854 |
| 5 | plasma membrane repair (GO:0001778) | 5.42386852 |
| 6 | actin-mediated cell contraction (GO:0070252) | 5.38013857 |
| 7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.34426210 |
| 8 | myofibril assembly (GO:0030239) | 5.04448999 |
| 9 | cardiac myofibril assembly (GO:0055003) | 4.96542430 |
| 10 | carnitine shuttle (GO:0006853) | 4.93924538 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.88675263 |
| 12 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.81000454 |
| 13 | tricarboxylic acid cycle (GO:0006099) | 4.70188163 |
| 14 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.69655077 |
| 15 | fatty acid transmembrane transport (GO:1902001) | 4.50155042 |
| 16 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.44193524 |
| 17 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.42058725 |
| 18 | cardiac muscle contraction (GO:0060048) | 4.39787868 |
| 19 | striated muscle contraction (GO:0006941) | 4.28096937 |
| 20 | skeletal muscle contraction (GO:0003009) | 4.12953607 |
| 21 | actin filament-based movement (GO:0030048) | 4.07760269 |
| 22 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.01499500 |
| 23 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.95119495 |
| 24 | lysine catabolic process (GO:0006554) | 3.93261490 |
| 25 | lysine metabolic process (GO:0006553) | 3.93261490 |
| 26 | actomyosin structure organization (GO:0031032) | 3.90530238 |
| 27 | 2-oxoglutarate metabolic process (GO:0006103) | 3.89459140 |
| 28 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.89302164 |
| 29 | glycogen catabolic process (GO:0005980) | 3.82508514 |
| 30 | * regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.80939243 |
| 31 | carnitine transmembrane transport (GO:1902603) | 3.79965041 |
| 32 | cardiac muscle cell development (GO:0055013) | 3.77543582 |
| 33 | heart contraction (GO:0060047) | 3.76321840 |
| 34 | heart process (GO:0003015) | 3.76321840 |
| 35 | creatine metabolic process (GO:0006600) | 3.68907698 |
| 36 | response to inactivity (GO:0014854) | 3.68856867 |
| 37 | carnitine transport (GO:0015879) | 3.66717554 |
| 38 | amino-acid betaine transport (GO:0015838) | 3.66717554 |
| 39 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.66014817 |
| 40 | regulation of actin filament-based movement (GO:1903115) | 3.65896043 |
| 41 | aspartate family amino acid catabolic process (GO:0009068) | 3.65624083 |
| 42 | skeletal muscle fiber development (GO:0048741) | 3.64808171 |
| 43 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.61364223 |
| 44 | glucan catabolic process (GO:0009251) | 3.59574094 |
| 45 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.59147387 |
| 46 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.59147387 |
| 47 | cardiac cell development (GO:0055006) | 3.52108070 |
| 48 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.51024396 |
| 49 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.48118118 |
| 50 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.46621987 |
| 51 | NADH metabolic process (GO:0006734) | 3.46532279 |
| 52 | regulation of sequestering of triglyceride (GO:0010889) | 3.45662936 |
| 53 | regulation of cofactor metabolic process (GO:0051193) | 3.39143783 |
| 54 | regulation of coenzyme metabolic process (GO:0051196) | 3.39143783 |
| 55 | regulation of cell communication by electrical coupling (GO:0010649) | 3.37064551 |
| 56 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.36639066 |
| 57 | cellular polysaccharide catabolic process (GO:0044247) | 3.33185393 |
| 58 | sodium ion export (GO:0071436) | 3.32547537 |
| 59 | myotube cell development (GO:0014904) | 3.32264278 |
| 60 | cell communication by electrical coupling (GO:0010644) | 3.31153100 |
| 61 | cardiac muscle hypertrophy (GO:0003300) | 3.30765671 |
| 62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.30366520 |
| 63 | regulation of fatty acid oxidation (GO:0046320) | 3.30346544 |
| 64 | fatty acid beta-oxidation (GO:0006635) | 3.29974198 |
| 65 | skeletal muscle adaptation (GO:0043501) | 3.28479701 |
| 66 | * muscle contraction (GO:0006936) | 3.26981913 |
| 67 | striated muscle hypertrophy (GO:0014897) | 3.24260916 |
| 68 | adult heart development (GO:0007512) | 3.22110977 |
| 69 | detection of calcium ion (GO:0005513) | 3.20555369 |
| 70 | regulation of striated muscle contraction (GO:0006942) | 3.19664832 |
| 71 | relaxation of cardiac muscle (GO:0055119) | 3.18068140 |
| 72 | muscle fiber development (GO:0048747) | 3.17688860 |
| 73 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.17557099 |
| 74 | muscle cell cellular homeostasis (GO:0046716) | 3.17340053 |
| 75 | muscle cell fate commitment (GO:0042693) | 3.17115212 |
| 76 | cellular potassium ion homeostasis (GO:0030007) | 3.17097928 |
| 77 | heart trabecula formation (GO:0060347) | 3.16826330 |
| 78 | relaxation of muscle (GO:0090075) | 3.14534223 |
| 79 | acetyl-CoA metabolic process (GO:0006084) | 3.12979152 |
| 80 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.11089826 |
| 81 | polysaccharide catabolic process (GO:0000272) | 3.10590811 |
| 82 | regulation of ATP catabolic process (GO:1903289) | 3.08864148 |
| 83 | regulation of ATPase activity (GO:0043462) | 3.08864148 |
| 84 | regulation of relaxation of muscle (GO:1901077) | 3.06745530 |
| 85 | cell communication involved in cardiac conduction (GO:0086065) | 3.06391199 |
| 86 | positive regulation of fatty acid oxidation (GO:0046321) | 3.06244863 |
| 87 | * ventricular cardiac muscle cell action potential (GO:0086005) | 3.04954390 |
| 88 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.04494881 |
| 89 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.04494881 |
| 90 | gluconeogenesis (GO:0006094) | 3.02808230 |
| 91 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.02132882 |
| 92 | tricarboxylic acid metabolic process (GO:0072350) | 3.01803358 |
| 93 | glycogen biosynthetic process (GO:0005978) | 3.01098551 |
| 94 | glucan biosynthetic process (GO:0009250) | 3.01098551 |
| 95 | cellular response to epinephrine stimulus (GO:0071872) | 2.99871350 |
| 96 | * regulation of membrane repolarization (GO:0060306) | 2.98958824 |
| 97 | cardiac chamber formation (GO:0003207) | 2.98858888 |
| 98 | positive regulation of cation channel activity (GO:2001259) | 2.98127437 |
| 99 | response to epinephrine (GO:0071871) | 2.97921166 |
| 100 | activation of protein kinase A activity (GO:0034199) | 2.97414527 |
| 101 | * regulation of heart contraction (GO:0008016) | 2.96608444 |
| 102 | * muscle system process (GO:0003012) | 2.95390856 |
| 103 | quaternary ammonium group transport (GO:0015697) | 2.94180240 |
| 104 | succinate metabolic process (GO:0006105) | 2.93026728 |
| 105 | fatty acid homeostasis (GO:0055089) | 2.91766269 |
| 106 | short-chain fatty acid metabolic process (GO:0046459) | 2.91746653 |
| 107 | muscle tissue morphogenesis (GO:0060415) | 2.91452963 |
| 108 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.89268876 |
| 109 | response to muscle activity (GO:0014850) | 2.88584028 |
| 110 | oxaloacetate metabolic process (GO:0006107) | 2.88194438 |
| 111 | fatty acid catabolic process (GO:0009062) | 2.86044754 |
| 112 | regulation of cardiac muscle contraction (GO:0055117) | 2.85330865 |
| 113 | lipid oxidation (GO:0034440) | 2.84762731 |
| 114 | regulation of muscle contraction (GO:0006937) | 2.84723275 |
| 115 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.83786923 |
| 116 | fatty acid oxidation (GO:0019395) | 2.83313537 |
| 117 | striated muscle adaptation (GO:0014888) | 2.83155150 |
| 118 | biotin metabolic process (GO:0006768) | 2.82666779 |
| 119 | regulation of the force of heart contraction (GO:0002026) | 2.82653914 |
| 120 | regulation of muscle system process (GO:0090257) | 2.82590229 |
| 121 | muscle hypertrophy (GO:0014896) | 2.81558729 |
| 122 | * regulation of heart rate (GO:0002027) | 2.80915999 |
| 123 | cardiac ventricle formation (GO:0003211) | 2.79670624 |
| 124 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.79483348 |
| 125 | muscle adaptation (GO:0043500) | 2.79471731 |
| 126 | positive regulation of myotube differentiation (GO:0010831) | 2.78852799 |
| 127 | glycogen metabolic process (GO:0005977) | 2.75330225 |
| 128 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.74454010 |
| 129 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.72561394 |
| 130 | negative regulation of potassium ion transport (GO:0043267) | 2.72080645 |
| 131 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.71312947 |
| 132 | cellular glucan metabolic process (GO:0006073) | 2.70281889 |
| 133 | glucan metabolic process (GO:0044042) | 2.70281889 |
| 134 | cardiac muscle adaptation (GO:0014887) | 2.69986039 |
| 135 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.69986039 |
| 136 | muscle hypertrophy in response to stress (GO:0003299) | 2.69986039 |
| 137 | negative regulation of protein localization to cell surface (GO:2000009) | 2.68741388 |
| 138 | regulation of sulfur metabolic process (GO:0042762) | 2.67799539 |
| 139 | striated muscle cell development (GO:0055002) | 2.65928553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.71618542 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.44676911 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.14333425 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.98737037 |
| 5 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.93221003 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.92169010 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.77281518 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.63294438 |
| 9 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.35390193 |
| 10 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.33493963 |
| 11 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.33493963 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.30851263 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.18014012 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.17407211 |
| 15 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.17044274 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.10120541 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.98278817 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.89096535 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.78913238 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.77836825 |
| 21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.65193826 |
| 22 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.58463158 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58070501 |
| 24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.57525739 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.57300750 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54174748 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.54032210 |
| 28 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47043087 |
| 29 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.41814147 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40764516 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39405051 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39351897 |
| 33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38255674 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37868562 |
| 35 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36324053 |
| 36 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.35532788 |
| 37 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.35410256 |
| 38 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.34225342 |
| 39 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.32855819 |
| 40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.32776341 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30721617 |
| 42 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.28488039 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.28488039 |
| 44 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27879045 |
| 45 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.23667385 |
| 46 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23277748 |
| 47 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22940203 |
| 48 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.22825475 |
| 49 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22515963 |
| 50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.22485015 |
| 51 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.21870072 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21375109 |
| 53 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21225859 |
| 54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20120184 |
| 55 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19661635 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19012992 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17001189 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16685268 |
| 59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15907047 |
| 60 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15831785 |
| 61 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15353982 |
| 62 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15047455 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14881632 |
| 64 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.13734937 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12240441 |
| 66 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.11763411 |
| 67 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09907811 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09496119 |
| 69 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.07524492 |
| 70 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07336258 |
| 71 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.07254666 |
| 72 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.06329489 |
| 73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05518110 |
| 74 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.03975697 |
| 75 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03055616 |
| 76 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.02542946 |
| 77 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.02345615 |
| 78 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02158033 |
| 79 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01836669 |
| 80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.00698652 |
| 81 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.00557459 |
| 82 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.00293739 |
| 83 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00115462 |
| 84 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00095586 |
| 85 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99445949 |
| 86 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99402503 |
| 87 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99150706 |
| 88 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.98840693 |
| 89 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98724544 |
| 90 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98525351 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98354791 |
| 92 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.96534606 |
| 93 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.95659526 |
| 94 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.95505801 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95409130 |
| 96 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95131268 |
| 97 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94880935 |
| 98 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.94660671 |
| 99 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.94252742 |
| 100 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93465452 |
| 101 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.93386252 |
| 102 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.93253755 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92250370 |
| 104 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.91816459 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.91698419 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.89820923 |
| 107 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89192796 |
| 108 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.89084820 |
| 109 | P68_20966046_ChIP-Seq_HELA_Human | 0.88896071 |
| 110 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88191977 |
| 111 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86885090 |
| 112 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.86430703 |
| 113 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85680228 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85560736 |
| 115 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.85487983 |
| 116 | CJUN_26792858_Chip-Seq_BT549_Human | 0.83130915 |
| 117 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82948660 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82065731 |
| 119 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.79933217 |
| 120 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.78326895 |
| 121 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78146300 |
| 122 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.77819696 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77724877 |
| 124 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77724877 |
| 125 | SA1_27219007_Chip-Seq_Bcells_Human | 0.77230571 |
| 126 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.76849865 |
| 127 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.76779698 |
| 128 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.76665938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.14483098 |
| 2 | MP0000751_myopathy | 4.83419875 |
| 3 | MP0003646_muscle_fatigue | 4.75779565 |
| 4 | MP0000749_muscle_degeneration | 4.14353148 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.61943232 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.52741982 |
| 7 | MP0004145_abnormal_muscle_electrophysio | 3.46744725 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.06712163 |
| 9 | MP0005330_cardiomyopathy | 2.93703540 |
| 10 | MP0004130_abnormal_muscle_cell | 2.90590940 |
| 11 | MP0004087_abnormal_muscle_fiber | 2.86349105 |
| 12 | MP0000750_abnormal_muscle_regeneration | 2.77254537 |
| 13 | MP0000747_muscle_weakness | 2.74225523 |
| 14 | MP0002269_muscular_atrophy | 2.62778070 |
| 15 | MP0005620_abnormal_muscle_contractility | 2.55001765 |
| 16 | MP0002106_abnormal_muscle_physiology | 2.54549933 |
| 17 | MP0000759_abnormal_skeletal_muscle | 2.26923529 |
| 18 | MP0002972_abnormal_cardiac_muscle | 2.21222531 |
| 19 | MP0005451_abnormal_body_composition | 2.20840133 |
| 20 | MP0005369_muscle_phenotype | 2.14061888 |
| 21 | MP0005670_abnormal_white_adipose | 2.09285270 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.04740687 |
| 23 | MP0003137_abnormal_impulse_conducting | 1.95923511 |
| 24 | MP0005666_abnormal_adipose_tissue | 1.94107754 |
| 25 | MP0004233_abnormal_muscle_weight | 1.90944638 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.82924682 |
| 27 | MP0008775_abnormal_heart_ventricle | 1.77300506 |
| 28 | MP0010630_abnormal_cardiac_muscle | 1.76796793 |
| 29 | MP0001544_abnormal_cardiovascular_syste | 1.76375615 |
| 30 | MP0005385_cardiovascular_system_phenoty | 1.76375615 |
| 31 | MP0004484_altered_response_of | 1.70079427 |
| 32 | MP0006138_congestive_heart_failure | 1.66532556 |
| 33 | MP0005360_urolithiasis | 1.65354021 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.61110093 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.58320708 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.57907604 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.52229002 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.49920410 |
| 39 | MP0003279_aneurysm | 1.46199571 |
| 40 | MP0009840_abnormal_foam_cell | 1.42255784 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.40485449 |
| 42 | MP0005375_adipose_tissue_phenotype | 1.35734845 |
| 43 | MP0002108_abnormal_muscle_morphology | 1.35659996 |
| 44 | MP0005423_abnormal_somatic_nervous | 1.32559030 |
| 45 | MP0003879_abnormal_hair_cell | 1.30436180 |
| 46 | MP0004085_abnormal_heartbeat | 1.28431349 |
| 47 | MP0000013_abnormal_adipose_tissue | 1.26747735 |
| 48 | MP0005332_abnormal_amino_acid | 1.21361412 |
| 49 | MP0002971_abnormal_brown_adipose | 1.21040190 |
| 50 | MP0005275_abnormal_skin_tensile | 1.20236041 |
| 51 | MP0008569_lethality_at_weaning | 1.19744429 |
| 52 | MP0005085_abnormal_gallbladder_physiolo | 1.19679767 |
| 53 | MP0002127_abnormal_cardiovascular_syste | 1.18429277 |
| 54 | MP0001661_extended_life_span | 1.09056207 |
| 55 | MP0003221_abnormal_cardiomyocyte_apopto | 1.09011553 |
| 56 | * MP0003635_abnormal_synaptic_transmissio | 1.07575352 |
| 57 | MP0000733_abnormal_muscle_development | 1.05715993 |
| 58 | MP0009384_cardiac_valve_regurgitation | 1.05221995 |
| 59 | MP0005365_abnormal_bile_salt | 1.04158411 |
| 60 | MP0003828_pulmonary_edema | 1.02283375 |
| 61 | MP0005623_abnormal_meninges_morphology | 1.01778693 |
| 62 | MP0002064_seizures | 1.01429152 |
| 63 | MP0010329_abnormal_lipoprotein_level | 1.00501320 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 0.97320772 |
| 65 | MP0004043_abnormal_pH_regulation | 0.96934668 |
| 66 | MP0003252_abnormal_bile_duct | 0.95712920 |
| 67 | MP0000343_altered_response_to | 0.94144418 |
| 68 | MP0002734_abnormal_mechanical_nocicepti | 0.89619735 |
| 69 | MP0002118_abnormal_lipid_homeostasis | 0.88657772 |
| 70 | MP0005165_increased_susceptibility_to | 0.88293099 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 0.86767601 |
| 72 | MP0002063_abnormal_learning/memory/cond | 0.84195864 |
| 73 | MP0009745_abnormal_behavioral_response | 0.83824922 |
| 74 | MP0005083_abnormal_biliary_tract | 0.83315084 |
| 75 | MP0005266_abnormal_metabolism | 0.83255627 |
| 76 | MP0001958_emphysema | 0.82970165 |
| 77 | MP0002272_abnormal_nervous_system | 0.82967873 |
| 78 | MP0004510_myositis | 0.81452861 |
| 79 | MP0003329_amyloid_beta_deposits | 0.81065161 |
| 80 | MP0003880_abnormal_central_pattern | 0.80824003 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.79179962 |
| 82 | MP0000003_abnormal_adipose_tissue | 0.78915182 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.78475477 |
| 84 | MP0002909_abnormal_adrenal_gland | 0.77683883 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77314844 |
| 86 | MP0003690_abnormal_glial_cell | 0.77041778 |
| 87 | MP0004858_abnormal_nervous_system | 0.76907979 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.76621298 |
| 89 | MP0000266_abnormal_heart_morphology | 0.75969861 |
| 90 | MP0009780_abnormal_chondrocyte_physiolo | 0.75821068 |
| 91 | MP0008961_abnormal_basal_metabolism | 0.75441136 |
| 92 | MP0002822_catalepsy | 0.75406625 |
| 93 | MP0004272_abnormal_basement_membrane | 0.72867323 |
| 94 | MP0009115_abnormal_fat_cell | 0.71339752 |
| 95 | MP0008875_abnormal_xenobiotic_pharmacok | 0.68549267 |
| 96 | MP0001486_abnormal_startle_reflex | 0.67494528 |
| 97 | MP0002078_abnormal_glucose_homeostasis | 0.65942699 |
| 98 | MP0010368_abnormal_lymphatic_system | 0.65535717 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.63361192 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.62978450 |
| 101 | MP0003045_fibrosis | 0.62751500 |
| 102 | MP0003011_delayed_dark_adaptation | 0.62486496 |
| 103 | MP0002249_abnormal_larynx_morphology | 0.61388040 |
| 104 | MP0003195_calcinosis | 0.61292104 |
| 105 | MP0002128_abnormal_blood_circulation | 0.60094210 |
| 106 | * MP0002066_abnormal_motor_capabilities/c | 0.60066978 |
| 107 | MP0000920_abnormal_myelination | 0.59731389 |
| 108 | MP0005535_abnormal_body_temperature | 0.59538819 |
| 109 | MP0004270_analgesia | 0.57842123 |
| 110 | MP0005334_abnormal_fat_pad | 0.56833998 |
| 111 | MP0002572_abnormal_emotion/affect_behav | 0.56463076 |
| 112 | MP0001502_abnormal_circadian_rhythm | 0.55774907 |
| 113 | MP0001299_abnormal_eye_distance/ | 0.54233960 |
| 114 | MP0002254_reproductive_system_inflammat | 0.52312435 |
| 115 | MP0001501_abnormal_sleep_pattern | 0.51172956 |
| 116 | MP0004147_increased_porphyrin_level | 0.50049209 |
| 117 | MP0005503_abnormal_tendon_morphology | 0.50041093 |
| 118 | MP0010030_abnormal_orbit_morphology | 0.49589592 |
| 119 | MP0000609_abnormal_liver_physiology | 0.49527910 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.48996718 |
| 121 | MP0004859_abnormal_synaptic_plasticity | 0.48315416 |
| 122 | MP0008874_decreased_physiological_sensi | 0.48288505 |
| 123 | MP0001440_abnormal_grooming_behavior | 0.48157332 |
| 124 | * MP0003634_abnormal_glial_cell | 0.47560895 |
| 125 | MP0004924_abnormal_behavior | 0.47361711 |
| 126 | MP0005386_behavior/neurological_phenoty | 0.47361711 |
| 127 | MP0002896_abnormal_bone_mineralization | 0.47311991 |
| 128 | MP0003633_abnormal_nervous_system | 0.46860210 |
| 129 | MP0000762_abnormal_tongue_morphology | 0.46587097 |
| 130 | MP0002067_abnormal_sensory_capabilities | 0.44233644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 6.70484243 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 6.24187279 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 5.40417214 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.38685240 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 5.37742396 |
| 6 | Muscle fiber splitting (HP:0003555) | 5.36143097 |
| 7 | Sudden death (HP:0001699) | 5.22853828 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.17275711 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 5.09085869 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 4.98764519 |
| 11 | Myoglobinuria (HP:0002913) | 4.95608367 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 4.58720168 |
| 13 | Nemaline bodies (HP:0003798) | 4.51554728 |
| 14 | Difficulty running (HP:0009046) | 4.36700596 |
| 15 | Increased connective tissue (HP:0009025) | 4.25357791 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.18597277 |
| 17 | Ventricular tachycardia (HP:0004756) | 4.02142418 |
| 18 | Asymmetric septal hypertrophy (HP:0001670) | 3.88342669 |
| 19 | Rhabdomyolysis (HP:0003201) | 3.73931544 |
| 20 | Subaortic stenosis (HP:0001682) | 3.70384885 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.70384885 |
| 22 | Distal arthrogryposis (HP:0005684) | 3.58477506 |
| 23 | Myotonia (HP:0002486) | 3.53372039 |
| 24 | Round ear (HP:0100830) | 3.50161355 |
| 25 | Muscle stiffness (HP:0003552) | 3.47245153 |
| 26 | Right ventricular cardiomyopathy (HP:0011663) | 3.35748863 |
| 27 | Difficulty climbing stairs (HP:0003551) | 3.32337440 |
| 28 | Lipoatrophy (HP:0100578) | 3.26998383 |
| 29 | Atrial fibrillation (HP:0005110) | 3.26872467 |
| 30 | Myopathic facies (HP:0002058) | 3.20498172 |
| 31 | Increased variability in muscle fiber diameter (HP:0003557) | 3.18932454 |
| 32 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.12636623 |
| 33 | Primary atrial arrhythmia (HP:0001692) | 3.02826441 |
| 34 | Bundle branch block (HP:0011710) | 3.00429422 |
| 35 | Supraventricular tachycardia (HP:0004755) | 2.88836875 |
| 36 | Supraventricular arrhythmia (HP:0005115) | 2.85394629 |
| 37 | Ulnar deviation of the wrist (HP:0003049) | 2.79372664 |
| 38 | Dilated cardiomyopathy (HP:0001644) | 2.77118095 |
| 39 | Ketoacidosis (HP:0001993) | 2.73574526 |
| 40 | Neck muscle weakness (HP:0000467) | 2.66761646 |
| 41 | Heart block (HP:0012722) | 2.62965941 |
| 42 | Hyperglycinuria (HP:0003108) | 2.61102791 |
| 43 | Palpitations (HP:0001962) | 2.60231151 |
| 44 | * Ventricular arrhythmia (HP:0004308) | 2.59907876 |
| 45 | Bulbar palsy (HP:0001283) | 2.58619035 |
| 46 | Abnormal atrioventricular conduction (HP:0005150) | 2.55441752 |
| 47 | Atrioventricular block (HP:0001678) | 2.53977460 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.50291873 |
| 49 | Ragged-red muscle fibers (HP:0003200) | 2.46228177 |
| 50 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.45814893 |
| 51 | Ketosis (HP:0001946) | 2.44032298 |
| 52 | EMG: neuropathic changes (HP:0003445) | 2.35725653 |
| 53 | Areflexia of lower limbs (HP:0002522) | 2.35179804 |
| 54 | Lower limb amyotrophy (HP:0007210) | 2.33873341 |
| 55 | Hypoalphalipoproteinemia (HP:0003233) | 2.31352507 |
| 56 | Scapular winging (HP:0003691) | 2.29586160 |
| 57 | Calcaneovalgus deformity (HP:0001848) | 2.26872104 |
| 58 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.26417363 |
| 59 | Abnormality of glycine metabolism (HP:0010895) | 2.26417363 |
| 60 | * Syncope (HP:0001279) | 2.25450632 |
| 61 | Frequent falls (HP:0002359) | 2.22537687 |
| 62 | Limb-girdle muscle atrophy (HP:0003797) | 2.18115644 |
| 63 | Ventricular fibrillation (HP:0001663) | 2.17469267 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 2.16568005 |
| 65 | Achilles tendon contracture (HP:0001771) | 2.16418094 |
| 66 | Hypoglycemic coma (HP:0001325) | 2.12268212 |
| 67 | Muscular dystrophy (HP:0003560) | 2.10305968 |
| 68 | Spinal rigidity (HP:0003306) | 2.09244717 |
| 69 | Gout (HP:0001997) | 2.07775965 |
| 70 | Absent phalangeal crease (HP:0006109) | 2.07596313 |
| 71 | Generalized muscle weakness (HP:0003324) | 2.07485758 |
| 72 | Gowers sign (HP:0003391) | 2.07088147 |
| 73 | Hyperammonemia (HP:0001987) | 2.05784722 |
| 74 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.05315780 |
| 75 | * Prolonged QT interval (HP:0001657) | 2.05023448 |
| 76 | Facial diplegia (HP:0001349) | 2.04532789 |
| 77 | Deformed tarsal bones (HP:0008119) | 2.03849230 |
| 78 | Rimmed vacuoles (HP:0003805) | 2.02915873 |
| 79 | Hypoplastic ischia (HP:0003175) | 2.00718540 |
| 80 | Myokymia (HP:0002411) | 1.97460022 |
| 81 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.94422498 |
| 82 | Waddling gait (HP:0002515) | 1.88196490 |
| 83 | Distal lower limb amyotrophy (HP:0008944) | 1.88121892 |
| 84 | Testicular atrophy (HP:0000029) | 1.87441439 |
| 85 | Weak cry (HP:0001612) | 1.86034027 |
| 86 | Congenital malformation of the right heart (HP:0011723) | 1.85923127 |
| 87 | Double outlet right ventricle (HP:0001719) | 1.85923127 |
| 88 | Broad metatarsal (HP:0001783) | 1.84950842 |
| 89 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.83205799 |
| 90 | Left ventricular hypertrophy (HP:0001712) | 1.82859487 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.82814694 |
| 92 | Dicarboxylic aciduria (HP:0003215) | 1.82814694 |
| 93 | Fetal akinesia sequence (HP:0001989) | 1.82791180 |
| 94 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.82148861 |
| 95 | Cholelithiasis (HP:0001081) | 1.81811564 |
| 96 | Hypoplastic left heart (HP:0004383) | 1.81749278 |
| 97 | Xanthomatosis (HP:0000991) | 1.80729915 |
| 98 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.79782960 |
| 99 | Proximal amyotrophy (HP:0007126) | 1.79578855 |
| 100 | Cerebral aneurysm (HP:0004944) | 1.79560195 |
| 101 | Hypoplastic heart (HP:0001961) | 1.79471465 |
| 102 | Abnormality of the ischium (HP:0003174) | 1.78974422 |
| 103 | Ankle clonus (HP:0011448) | 1.76655270 |
| 104 | Abnormal finger flexion creases (HP:0006143) | 1.74798273 |
| 105 | Progressive muscle weakness (HP:0003323) | 1.73805397 |
| 106 | Hyperglycinemia (HP:0002154) | 1.73561757 |
| 107 | Hip contracture (HP:0003273) | 1.73401179 |
| 108 | * Abnormal EKG (HP:0003115) | 1.73232387 |
| 109 | Foot dorsiflexor weakness (HP:0009027) | 1.72056877 |
| 110 | Steppage gait (HP:0003376) | 1.71623197 |
| 111 | Protrusio acetabuli (HP:0003179) | 1.71102459 |
| 112 | Abnormality of the foot musculature (HP:0001436) | 1.71054192 |
| 113 | Premature rupture of membranes (HP:0001788) | 1.70945569 |
| 114 | Slender build (HP:0001533) | 1.69496759 |
| 115 | Limb-girdle muscle weakness (HP:0003325) | 1.69053003 |
| 116 | Malignant hyperthermia (HP:0002047) | 1.67400586 |
| 117 | Dysmetric saccades (HP:0000641) | 1.62257776 |
| 118 | Exercise intolerance (HP:0003546) | 1.60104870 |
| 119 | Abnormality of the neuromuscular junction (HP:0003398) | 1.55582338 |
| 120 | Fatigable weakness (HP:0003473) | 1.55582338 |
| 121 | Abnormality of the tricuspid valve (HP:0001702) | 1.54191156 |
| 122 | Sudden cardiac death (HP:0001645) | 1.53364507 |
| 123 | Abnormality of glycolysis (HP:0004366) | 1.53010490 |
| 124 | Stridor (HP:0010307) | 1.50277986 |
| 125 | Abnormality of the calcaneus (HP:0008364) | 1.49734703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.18495087 |
| 2 | OBSCN | 5.05203434 |
| 3 | PHKG1 | 4.21716920 |
| 4 | PHKG2 | 4.21716920 |
| 5 | TRIB3 | 3.77810409 |
| 6 | PDK3 | 2.72162566 |
| 7 | PDK4 | 2.72162566 |
| 8 | BCKDK | 2.65367704 |
| 9 | LMTK2 | 2.60476891 |
| 10 | PKN2 | 2.47163458 |
| 11 | NEK1 | 2.20340924 |
| 12 | DMPK | 2.14358124 |
| 13 | PINK1 | 2.06225121 |
| 14 | MYLK | 1.90742215 |
| 15 | PDK2 | 1.82716427 |
| 16 | MARK1 | 1.81378600 |
| 17 | SIK1 | 1.60641742 |
| 18 | PIK3CG | 1.54864510 |
| 19 | PIK3CA | 1.53294890 |
| 20 | MAP3K7 | 1.45434597 |
| 21 | PRPF4B | 1.44194331 |
| 22 | RIPK1 | 1.43016354 |
| 23 | MUSK | 1.41017795 |
| 24 | NME1 | 1.40124818 |
| 25 | MAP2K3 | 1.35687906 |
| 26 | ARAF | 1.30957468 |
| 27 | NTRK3 | 1.24498748 |
| 28 | EEF2K | 1.23725038 |
| 29 | LATS2 | 1.21993905 |
| 30 | LIMK1 | 1.21517538 |
| 31 | EPHA4 | 1.21072116 |
| 32 | UHMK1 | 1.14921149 |
| 33 | MAP2K4 | 1.14156219 |
| 34 | TGFBR2 | 1.12863849 |
| 35 | ERN1 | 1.10460074 |
| 36 | DAPK2 | 1.10333829 |
| 37 | STK38 | 1.07937089 |
| 38 | MAPKAPK3 | 1.06215865 |
| 39 | PDGFRA | 1.03274453 |
| 40 | PAK3 | 0.99587356 |
| 41 | DDR2 | 0.99494987 |
| 42 | CAMK1D | 0.98958016 |
| 43 | CAMK2B | 0.97354100 |
| 44 | STK38L | 0.92675520 |
| 45 | PRKAA2 | 0.90239510 |
| 46 | PRKAA1 | 0.89647248 |
| 47 | PRKD3 | 0.88483422 |
| 48 | KSR2 | 0.86506904 |
| 49 | PRKD1 | 0.86450678 |
| 50 | ROCK1 | 0.82329584 |
| 51 | WNK4 | 0.82021233 |
| 52 | * MAPK12 | 0.80841395 |
| 53 | MAP3K3 | 0.80160439 |
| 54 | CAMK1G | 0.78392483 |
| 55 | PAK6 | 0.78026294 |
| 56 | TIE1 | 0.76961462 |
| 57 | ILK | 0.75780240 |
| 58 | MARK2 | 0.73894118 |
| 59 | MAP3K9 | 0.69335661 |
| 60 | STK24 | 0.68839893 |
| 61 | ICK | 0.67727715 |
| 62 | CDC42BPA | 0.67512536 |
| 63 | PDPK1 | 0.66600289 |
| 64 | LATS1 | 0.65996474 |
| 65 | PTK2B | 0.65793969 |
| 66 | TAOK1 | 0.64442802 |
| 67 | SGK223 | 0.61709100 |
| 68 | SGK494 | 0.61709100 |
| 69 | EPHB1 | 0.60928951 |
| 70 | PTK6 | 0.59057232 |
| 71 | CAMK2D | 0.57057679 |
| 72 | MAP3K11 | 0.55057299 |
| 73 | CCNB1 | 0.54927362 |
| 74 | AKT2 | 0.53550419 |
| 75 | CDK5 | 0.53017872 |
| 76 | NTRK2 | 0.52023270 |
| 77 | MAP3K5 | 0.50292614 |
| 78 | CAMK4 | 0.50218455 |
| 79 | CAMK2G | 0.50019425 |
| 80 | TESK1 | 0.49742916 |
| 81 | BRAF | 0.49473606 |
| 82 | SGK2 | 0.49255579 |
| 83 | MAP3K13 | 0.48263098 |
| 84 | GRK7 | 0.47951690 |
| 85 | DYRK1B | 0.47295043 |
| 86 | PDK1 | 0.46616756 |
| 87 | DAPK3 | 0.46580924 |
| 88 | MAP3K1 | 0.45904735 |
| 89 | MAPK11 | 0.45244243 |
| 90 | FER | 0.44252632 |
| 91 | MAP2K1 | 0.44192825 |
| 92 | PRKG1 | 0.43553356 |
| 93 | BMX | 0.42369398 |
| 94 | SGK3 | 0.41913173 |
| 95 | RET | 0.41728988 |
| 96 | CAMKK1 | 0.41588983 |
| 97 | PRKCH | 0.41315093 |
| 98 | * MAPK4 | 0.40972378 |
| 99 | * MAPK10 | 0.40613729 |
| 100 | PRKACG | 0.39755365 |
| 101 | CAMK1 | 0.39523592 |
| 102 | PKN1 | 0.39167522 |
| 103 | WNK1 | 0.39139301 |
| 104 | ROCK2 | 0.39013884 |
| 105 | PRKACB | 0.38191807 |
| 106 | SMG1 | 0.37762777 |
| 107 | MAP2K6 | 0.37217023 |
| 108 | RAF1 | 0.36563816 |
| 109 | MAPK7 | 0.36080724 |
| 110 | CAMK2A | 0.35942163 |
| 111 | MAP3K4 | 0.35076745 |
| 112 | FGFR4 | 0.34830628 |
| 113 | PAK2 | 0.34627037 |
| 114 | MOS | 0.34581483 |
| 115 | STK11 | 0.34011529 |
| 116 | MTOR | 0.33479959 |
| 117 | RPS6KA2 | 0.33249885 |
| 118 | NEK9 | 0.33081710 |
| 119 | TRPM7 | 0.33074643 |
| 120 | NTRK1 | 0.32808643 |
| 121 | TAOK2 | 0.31690481 |
| 122 | FLT3 | 0.31186451 |
| 123 | GRK5 | 0.31091098 |
| 124 | TYRO3 | 0.31033923 |
| 125 | RPS6KL1 | 0.31019521 |
| 126 | RPS6KC1 | 0.31019521 |
| 127 | PRKACA | 0.30992922 |
| 128 | PRKG2 | 0.30256927 |
| 129 | SGK1 | 0.29286633 |
| 130 | RPS6KA3 | 0.28871086 |
| 131 | EPHB2 | 0.28369529 |
| 132 | PTK2 | 0.28298439 |
| 133 | MAP3K10 | 0.26762733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.97796175 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.61186408 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06171580 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.02020691 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.95405735 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.85002811 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.51030585 |
| 8 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.45398320 |
| 9 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.42229491 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38450893 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.37976781 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.19485079 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.17782011 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.97819282 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.86993267 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86363591 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.85258423 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72443745 |
| 19 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.70076585 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.67748438 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.51164052 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.48344367 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.44187176 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.41114246 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40783920 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.33773867 |
| 27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.29484193 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.23709702 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.22783671 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.22285148 |
| 31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19778683 |
| 32 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.18819330 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.18598938 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.15907470 |
| 35 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.15083764 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.13685086 |
| 37 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.12950609 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.12229999 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10734902 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07565062 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05379712 |
| 42 | Insulin resistance_Homo sapiens_hsa04931 | 1.05036610 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99716145 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.98231538 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97727086 |
| 46 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.96147110 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88549827 |
| 48 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.87419191 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83103009 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83005401 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82992778 |
| 52 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.82626697 |
| 53 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79839970 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 0.75618468 |
| 55 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.75092519 |
| 56 | Melanogenesis_Homo sapiens_hsa04916 | 0.74346362 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73308288 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71786779 |
| 59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.71341592 |
| 60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71092043 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.70315752 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69157072 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69084803 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68728070 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65549696 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.65434133 |
| 67 | Cocaine addiction_Homo sapiens_hsa05030 | 0.65242718 |
| 68 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64727302 |
| 69 | Focal adhesion_Homo sapiens_hsa04510 | 0.62714198 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62351555 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61116229 |
| 72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61006336 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60159189 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60007171 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.59824491 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59607901 |
| 77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58565807 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.57823088 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57382958 |
| 80 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57247070 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.55256187 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53575139 |
| 83 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53462486 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.52355640 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51887560 |
| 86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49142081 |
| 87 | Tight junction_Homo sapiens_hsa04530 | 0.49125125 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48981258 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48920628 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47895003 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47772292 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46938341 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46886447 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46534271 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45181877 |
| 96 | Nicotine addiction_Homo sapiens_hsa05033 | 0.45141386 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43712695 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.43124173 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41775821 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41690459 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40801805 |
| 102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39153687 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38705001 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38700841 |
| 105 | Insulin secretion_Homo sapiens_hsa04911 | 0.38455698 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36815124 |
| 107 | Salivary secretion_Homo sapiens_hsa04970 | 0.36339306 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35617180 |
| 109 | Long-term depression_Homo sapiens_hsa04730 | 0.34021536 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.33611998 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33494375 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33489373 |
| 113 | ABC transporters_Homo sapiens_hsa02010 | 0.32930089 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.32381603 |
| 115 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.31071143 |
| 116 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.30661741 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.30266687 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30232184 |
| 119 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29786385 |
| 120 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.29305322 |
| 121 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.28877387 |
| 122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28238096 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27898107 |
| 124 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25717143 |
| 125 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.25190851 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24760795 |
| 127 | GABAergic synapse_Homo sapiens_hsa04727 | 0.23961409 |
| 128 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.23943236 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23548100 |
| 130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.23490786 |
| 131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23300138 |

